Related Experiment Video

Updated: Aug 10, 2026

Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

Guideline directed-medical therapy for heart failure within 3 months post LVAD implant and rehospitalization

Ernesto Ruiz-Duque1, Chris Kourek2, Paulino Alvarez3,4

  • 1Division of Cardiology, Department of Medicine, University of Iowa, Iowa City, IA.

JHLT Open
|August 8, 2026
PubMed

Insights

Guideline-directed medical therapy (GDMT) after LVAD implantation significantly reduced hospital readmissions. Early GDMT use showed a trend toward lower mortality, supporting further research into optimizing heart failure treatment.

Area of Science:

  • Cardiology
  • Medical Devices
  • Pharmacology

Background:

  • Guideline-directed medical therapy (GDMT) is crucial for heart failure with reduced ejection fraction (HFrEF).
  • GDMT use in patients with durable left ventricular assist devices (LVADs) is inconsistent.
  • Optimizing GDMT post-LVAD is essential for improving patient outcomes.

Purpose of the Study:

  • To evaluate the association between early GDMT initiation (within 3 months) after LVAD implantation and clinical outcomes.
  • To assess the impact of GDMT on all-cause hospital readmission and 12-month mortality in LVAD patients.

Main Methods:

  • Retrospective, single-center cohort study of adult patients undergoing durable LVAD implantation (2009-2024).
  • GDMT defined as ≥3 medication classes: beta-blockers, ACEIs/ARBs, ARNIs, MRAs, SGLT2i.
  • Comparison of outcomes between GDMT (≥3 classes) and Non-GDMT (<3 classes) groups.

Main Results:

  • 220 patients analyzed; 24.9% received GDMT, 75.1% did not.
  • GDMT group had lower NT-pro BNP levels and significantly less all-cause rehospitalization (71.4% vs. 88.5%).
  • Early GDMT independently associated with 62% lower odds of rehospitalization (OR 0.38, p=0.03).

Conclusions:

  • Early initiation of GDMT within 3 months post-LVAD implantation is linked to reduced hospital readmissions.
  • A trend towards lower 12-month mortality was observed with early GDMT, though not statistically significant.
  • Prospective studies are warranted to confirm the benefits of optimizing GDMT after LVAD implantation.
Abstract

Keywords:
Durable mechanical circulatory supportGuideline-directed medical therapyHeart failure with reduced ejection fractionLeft ventricular assist deviceRehospitalizationRight ventricular failure

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure05:18

Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure

Published on: January 16, 2026

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...